206results about How to "Efficient targeting" patented technology

Provided herein are antibodies specific for TIM3 that can be used to detect cancer cells, in particular, cancer stem cells. The antibodies can also be used in therapeutic compositions for treating cancer and reducing inflammation.

Provided herein are antibodies specific for TIM3 that can be used to detect cancer cells, in particular, cancer stem cells. The antibodies can also be used in therapeutic compositions for treating cancer and reducing inflammation.

Provided are transmembrane complexes that contain a protein transduction domain (PTD) from the N-terminus of IgE-dependent histamine-releasing factor (HRF) and a target substance that is to be delivered into a cell. Also provided are nucleic acid molecules encoding the transmembrane complex, and methods of delivering the target substance into a cell interior by contacting the transmembrane complex with a cell. Also provided are transfection kits containing the PTD and the target substance.

This invention is an improved method and device for treating varicose veins 200 or the greater saphenous vein 202. The method comprises the use of infrared laser radiation in the region of 1.2 to 2.2 um in a manner from inside the vessel 200 or 202 such that the endothelial cells of the vessel wall 704 are damaged and collagen fibers in the vessel wall 704 are heated to the point where they permanently contract, the vessel 200 or 202 is occluded and ultimately resorbed. The device includes a laser 102 delivered via a fiber optic catheter 300 that may have frosted or diffusing fiber tips 308, or that may be provided with a protective spacer. A motorized pull back device 104 may be used, and a thermal sensor 600 may be used to help control the power required to maintain the proper treatment temperature.

A device, system and method for producing glycosylated proteins in plant culture, particularly proteins having a high mannose glycosylation, while targeting such proteins with an ER signal and / or by-passing the Golgi. The invention further relates to vectors and methods for expression and production of enzymatically active high mannose lysosomal enzymes using transgenic plant root, particularly carrot cells. More particularly, the invention relates to host cells, particularly transgenic suspended carrot cells, vectors and methods for high yield expression and production of biologically active high mannose Glucocerebrosidase (GCD). The invention further provides for compositions and methods for the treatment of lysosomal storage diseases.

A supervision and penalty method and system for expressway emergency lane occupancy based on public supervision and reporting. The system includes a mobile terminal and a central computer. When a citizen notices a violation behavior of emergency lane occupancy of another vehicle, evidence is collected by photographing and images are uploaded to the central computer; meanwhile, user location information is automatically read and uploaded. The central computer acquires, through network transmission, image information and location information uploaded by a client, distinguishes whether it is a malicious reporting behavior and performs technical processing and license plate recognition on the uploaded images, checks the road section where the violation behavior occurs, and determines whether the violation behavior is an emergency lane violation behavior. The computer automatically searches for and matches owner information corresponding to the license plate number of the violation vehicle, and automatically sends a penalty decision from the background.

The invention provides pharmaceutical compositions comprising short single stranded oligonucleotides, of length of between 8 and 26 nucleobases which are complementary to human microRNAs selected from the group consisting of miR19b, miR21, miR122a, miR155 and miR375. The short oligonucleotides are particularly effective at alleviating miRNA repression in vivo. It is found that the incorporation of high affinity nucleotide analogues into the oligonucleotides results in highly effective anti-microRNA molecules which appear to function via the formation of almost irreversible duplexes with the miRNA target, rather than RNA cleavage based mechanisms, such as mechanisms associated with RNaseH or RISC.

A request for information (RFI) system is provided for use in communications networks including broadcast networks and the internet. In one implementation, a viewer of a cable television network enters an RFI input (1) to a digital set top box using a user remote. Based on this RFI input, the digital set top box transmits a data request (2) to an RFI data center. The RFI data center also receives asset data (3) from an asset database so as to associate the RFI input (1) with a particular asset. An RFI request (4) can then be transmitted to the appropriate asset provider. The asset provider can then provide a report such package of assets or follow-on information (5) back to the RFI data center. The RFI data center may then, in turn, provide the package of assets or follow-on information to a user data terminal, for example, of the cable television network viewer, via access through a web-portal or e-mail (6). The digital set top box may also record inputs from the user to verify consumption of assets and track data requests. Using this information, the RFI data center or an RFI platform may credit value to a rewards account established for the network user based on the user's verified consumption of assets and / or data requests. Further, the RFI data center or RFI platform may be used to collect consumer behavior information, including purchasing decisions made by the user after consumption of assets, and correlate the consumer behavior information with the user's verified asset consumption.

The present invention relates to a method of modulating development of a cell. The method includes the step of introducing into the cell a nucleic acid with the capacity to modulate development of the cell, the nucleic acid including a target site for binding of a microRNA, wherein the activity and / or concentration of the microRNA in the cell results in a level of activity and / or concentration of the nucleic acid in the cell sufficient to modulate development of the cell.

Herein-described are various methods for making a vaccine that are made of re-assembled virus like particles (VLP). First, the VLPs are disassembled into encapsidation intermediate populations. Each encapsidation intermediate population undergoes, for instance, chemical conjugation of unique peptide or nucleic moieties to form separate populations. Thereafter, a predetermined amount of each of the several (one or more) different encapsidation intermediates from the different populations is mixed and joined, forming intact VLPs, surrounding a nucleic acid core, that are composed of different encapsidation intermediate such that the reassembled VLP displays more than one peptide or nucleic acid. The nucleic acid can function either as a scaffold alone or can be engineered for the expression of an immunomodulatory protein in a eukaryotic cell.